|
2025
|
P/S
|
Pharmaceutical preparations for treating central nervous system diseases or disorders; pharmaceut... |
|
2024
|
Invention
|
Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors.
The present invention provid... |
|
|
Invention
|
Pim kinase inhibitors for treatment of myeloproliferative neoplasms and fibrosis associated with ... |
|
|
P/S
|
Pharmaceutical preparations |
|
|
Invention
|
Salts of a heterocyclic compound and crystalline forms, processes for preparing, therapeutic uses... |
|
|
Invention
|
Methods of treating schizophrenia.
Provided herein are methods for determining if a compound has... |
|
|
Invention
|
Salts, crystal forms, and production methods thereof.
Provided are salts of (S)-(4,5-dihydro-7H-... |
|
|
Invention
|
Compounds and compositions and uses thereof.
Disclosed are compounds of formula (I):
Disclosed... |
|
|
Invention
|
Multicyclic compounds and methods of use thereof.
Provided herein are multicyclic compounds, met... |
|
|
Invention
|
Methods of treating neurological and psychiatric disorders.
The present disclosure relates to me... |
|
2023
|
Invention
|
2-phenylmorpholine and 2-phenyl(thio)morpholine compounds and uses thereof. e.g.e.g., X, Y, R1, R... |
|
|
Invention
|
Methods of switching neuropsychiatric medications using ulotaront. Neuropsychiatric treatments, i... |
|
|
Invention
|
Pim1 inhibitor for treating myeloproliferative neoplasms. Methods for treatment of myeloprolifera... |
|
|
Invention
|
Ulotaront for treating anxiety and associated conditions. Neuropsychiatric treatments, including ... |
|
|
Invention
|
Jak2 and alk2 inhibitors and methods for their use.
Compounds having activity as inhibitors of A... |
|
|
Invention
|
Ulotaront for the adjuvant treatment of major depressive disorder |
|
|
Invention
|
Alk5 inhibitors for treating myelodysplastic syndrome.
Described herein are methods for treating... |
|
2022
|
Invention
|
Methods of treating metabolic disorders. Provided herein are compounds, pharmaceutical compositio... |
|
|
Invention
|
Formulations comprising heterocyclic protein kinase inhibitors.
Provided is a composition compri... |
|
|
Invention
|
Salts, crystal forms, and production methods thereof. Provided are salts of (S)-(4,5-dihydro-7H-t... |
|
|
Invention
|
Substituted sulfonamide-chroman compounds, and pharmaceutical compositions, and methods of use th... |
|
|
Invention
|
Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disorders.
... |
|
2021
|
Invention
|
1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders.
Disclosed are comp... |
|
|
Invention
|
Compounds and compositions and uses thereof. Disclosed are compounds of formula (I):
and pharma... |
|
2020
|
Invention
|
Formulations comprising heterocyclic protein kinase inhibitors. Provided is a composition compris... |
|
2019
|
Invention
|
Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors. The present invention provide... |
|
|
Invention
|
1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders. Disclosed are compo... |
|
2016
|
Invention
|
Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disorders. D... |
|
2012
|
Invention
|
Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors. 2 and X are as defined herein... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of sleep disorders. |
|
2011
|
Invention
|
Imidazo[1,2-b]pyridazine and pyrazolo[1 .5-a]pyrimidine derivatives and their use as protein kina... |
|
2010
|
Invention
|
Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protei... |
|
2007
|
Invention
|
Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinas... |
|
2005
|
P/S
|
Topical cream used for dry skin.
Aromatherapy products, namely, aromatherapy packs containing her... |
